10.28.14
Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and Gentag, Inc., a pioneer in disposable biosensors that can be read with near field communication (NFC) devices, announced that they have entered into a strategic development agreement. Under the terms of the agreement, Welch Allyn and Gentag will bring to market NFC technology for medical devices and sensors.
The partnership with Gentag enables Welch Allyn to continue providing innovative solutions in medical settings, and NFC will allow the extension of these technologies for remote patient monitoring worldwide.
“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, Welch Allyn president and CEO.
With Gentag’s NFC technology, it becomes possible to integrate ultrathin battery-less wireless sensors into various medical diagnostic applications. Sending patient measurement data wirelessly via near field communications will open up significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record.
“Welch Allyn has the knowledge, expertise and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said Gentag CEO John Peeters. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”
The partnership with Gentag enables Welch Allyn to continue providing innovative solutions in medical settings, and NFC will allow the extension of these technologies for remote patient monitoring worldwide.
“This collaborative opportunity will enable Welch Allyn to provide clinicians with smart monitoring solutions and improve patient access to cutting edge diagnostics,” said Stephen Meyer, Welch Allyn president and CEO.
With Gentag’s NFC technology, it becomes possible to integrate ultrathin battery-less wireless sensors into various medical diagnostic applications. Sending patient measurement data wirelessly via near field communications will open up significant opportunities for workflow efficiency gains and faster availability of clinical information in the Electronic Health Record.
“Welch Allyn has the knowledge, expertise and global market reach that will allow the globalization of NFC technologies in medical diagnostic settings,” said Gentag CEO John Peeters. “By combining our intellectual property and technology portfolios with Welch Allyn, we feel that patients will be better served by the worldwide availability of high quality wireless medical devices.”